The clinical pharmacology of alkylating agents in high-dose chemotherapy
- PMID: 11036954
- DOI: 10.1097/00001813-200008000-00002
The clinical pharmacology of alkylating agents in high-dose chemotherapy
Abstract
Alkylating agents are widely used in high-dose chemotherapy regimens in combination with hematological support. Knowledge about the pharmacokinetics and pharmacodynamics of these agents administered in high doses is critical for the safe and efficient use of these regimens. The aim of this review is to summarize the clinical pharmacology of the alkylating agents (including the platinum compounds) in high-dose chemotherapy. Differences between conventional and high doses will be discussed.
Similar articles
-
Recent advances in the biochemical pharmacology of selected alkylating agents.Transplant Proc. 1973 Sep;5(3):1167-70. Transplant Proc. 1973. PMID: 4738047 No abstract available.
-
Triazene compounds: mechanism of action and related DNA repair systems.Pharmacol Res. 2007 Oct;56(4):275-87. doi: 10.1016/j.phrs.2007.08.003. Epub 2007 Aug 9. Pharmacol Res. 2007. PMID: 17897837 Review.
-
Medical treatment and other combination regimens.Tumori. 2007 May-Jun;93(3):suppl 22-6. Tumori. 2007. PMID: 17679485 Review. No abstract available.
-
Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.N Engl J Med. 1971 Aug 26;285(9):475-9. doi: 10.1056/NEJM197108262850902. N Engl J Med. 1971. PMID: 5558887 No abstract available.
-
Bendamustine: mechanism of action and clinical data.Clin Adv Hematol Oncol. 2011 Aug;9(8 Suppl 19):1-11. Clin Adv Hematol Oncol. 2011. PMID: 22362008 Review.
Cited by
-
Dioscorea bulbifera polysaccharide and cyclophosphamide combination enhances anti-cervical cancer effect and attenuates immunosuppression and oxidative stress in mice.Sci Rep. 2016 Jan 12;5:19185. doi: 10.1038/srep19185. Sci Rep. 2016. PMID: 26753518 Free PMC article.
-
Antineoplastics Encapsulated in Nanostructured Lipid Carriers.Molecules. 2021 Nov 17;26(22):6929. doi: 10.3390/molecules26226929. Molecules. 2021. PMID: 34834022 Free PMC article. Review.
-
Pharmacogenetics as a Future Tool to Risk-Stratify Breast Cancer Patients According to Chemotoxicity Potential from the Doxorubicin Hydrochloride and Cyclophosphamide (AC) Regimen.Pharmaceuticals (Basel). 2025 Apr 7;18(4):539. doi: 10.3390/ph18040539. Pharmaceuticals (Basel). 2025. PMID: 40283974 Free PMC article.
-
Generalized Multifactor Dimensionality Reduction (GMDR) Analysis of Drug-Metabolizing Enzyme-Encoding Gene Polymorphisms may Predict Treatment Outcomes in Indian Breast Cancer Patients.World J Surg. 2016 Jul;40(7):1600-10. doi: 10.1007/s00268-015-3263-6. World J Surg. 2016. PMID: 26506825
-
High-dose thiotepa-related neurotoxicity and the role of tramadol in children.BMC Cancer. 2018 Feb 13;18(1):177. doi: 10.1186/s12885-018-4090-6. BMC Cancer. 2018. PMID: 29433564 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources